Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:602945rdf:typepubmed:Citationlld:pubmed
pubmed-article:602945lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:602945lifeskim:mentionsumls-concept:C0027022lld:lifeskim
pubmed-article:602945lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:602945lifeskim:mentionsumls-concept:C0032195lld:lifeskim
pubmed-article:602945lifeskim:mentionsumls-concept:C1704711lld:lifeskim
pubmed-article:602945lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:602945pubmed:dateCreated1978-3-21lld:pubmed
pubmed-article:602945pubmed:abstractTextGlycoproteins have been discovered to be important to platelet function both in normal and pathological states. We have studied membrane glycoprotein patterns in 16 patients with various myeloproliferative disorders. There was an abnormal ratio of glycoprotein I:glycoprotein IV in patients with myeloproliferative disease compared with controls. There was no discernible correlation between glycoprotein pattern and aggregation response or platelet count, but patients with megathrombocytes had higher values for glycoprotein IV than those without megathrombocytes. These experiments suggest that patients with myeloproliferative disorders may have alterations in membrane glycoproteins that could alter platelet function.lld:pubmed
pubmed-article:602945pubmed:languageenglld:pubmed
pubmed-article:602945pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:602945pubmed:citationSubsetIMlld:pubmed
pubmed-article:602945pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:602945pubmed:statusMEDLINElld:pubmed
pubmed-article:602945pubmed:issn0361-8609lld:pubmed
pubmed-article:602945pubmed:authorpubmed-author:JamiesonG AGAlld:pubmed
pubmed-article:602945pubmed:authorpubmed-author:OkumuraTTlld:pubmed
pubmed-article:602945pubmed:authorpubmed-author:BolinR BRBlld:pubmed
pubmed-article:602945pubmed:issnTypePrintlld:pubmed
pubmed-article:602945pubmed:volume3lld:pubmed
pubmed-article:602945pubmed:ownerNLMlld:pubmed
pubmed-article:602945pubmed:authorsCompleteYlld:pubmed
pubmed-article:602945pubmed:pagination63-71lld:pubmed
pubmed-article:602945pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:602945pubmed:meshHeadingpubmed-meshheading:602945-H...lld:pubmed
pubmed-article:602945pubmed:meshHeadingpubmed-meshheading:602945-B...lld:pubmed
pubmed-article:602945pubmed:meshHeadingpubmed-meshheading:602945-B...lld:pubmed
pubmed-article:602945pubmed:meshHeadingpubmed-meshheading:602945-M...lld:pubmed
pubmed-article:602945pubmed:meshHeadingpubmed-meshheading:602945-F...lld:pubmed
pubmed-article:602945pubmed:meshHeadingpubmed-meshheading:602945-M...lld:pubmed
pubmed-article:602945pubmed:meshHeadingpubmed-meshheading:602945-G...lld:pubmed
pubmed-article:602945pubmed:meshHeadingpubmed-meshheading:602945-C...lld:pubmed
pubmed-article:602945pubmed:meshHeadingpubmed-meshheading:602945-M...lld:pubmed
pubmed-article:602945pubmed:meshHeadingpubmed-meshheading:602945-P...lld:pubmed
pubmed-article:602945pubmed:year1977lld:pubmed
pubmed-article:602945pubmed:articleTitleChanges in distribution of platelet membrane glycoproteins in patients with myeloproliferative disorders.lld:pubmed
pubmed-article:602945pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:602945pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:602945lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:602945lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:602945lld:pubmed